We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Briumvi Accelagen Pty Ltd
Product name
Briumvi
Sponsor
Accepted date
Jul-2024
Active ingredients
ublituximab
Proposed indication
For the treatment of relapsing forms of multiple sclerosis
Application type
A (new medicine)
Publication date
Jul-2024